NR Munjal
Sh. N.R. Munjal is the Chairman and Managing Director of the Ind-Swift Group, a diversified pharmaceutical conglomerate with a legacy spanning over four decades. With more than 30 years of leadership experience, he has been instrumental in shaping the Group’s long-term vision, driving sustainable growth, and expanding its global footprint across 60+ countries.
Under his visionary guidance, the Ind-Swift Group—comprising Ind-Swift Laboratories Ltd. and Ind-Swift Ltd.—has grown into a leading pharmaceutical player with strategic offices in the USA, UK, Dubai, and China, and a workforce of over 1,500 professionals.
Key Responsibilities:
-
Defining and driving long-term strategic goals
-
Leading and mentoring senior leadership for effective business execution
-
Identifying new avenues for innovation and global growth
-
Building and nurturing a high-performance, ethical, and collaborative organizational culture
Sh. N.R. Munjal’s foresight and dynamic leadership have not only steered the company toward operational excellence but have also played a pivotal role in reinforcing its position as a trusted name in global healthcare.
